Delivery Order SPE2DE23D0008-SPE2D626F42VU
Award Date 2/3/26
Potential Completion Date 2/6/26
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,200 fixed-price delivery order contract on February 3, 2026, for Natrelle Inspira SCF 415CC breast implants. The contract, which carries an ultimate completion date of February 6, 2026, represents a child order issued under one of Allergan's larger Indefinite Delivery/Indefinite Quantity (IDV) vehicles—specifically the $13.5 million Natrelle breast implants and surgical devices IDV established with the Defense Logistics Agency...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a fixed-price delivery order valued at $2,814.00 for Natrelle Inspira SCF 335CC breast implants by the Defense Logistics Agency's Medical Supply Chain division. The award was issued on January 22, 2026, with an ultimate completion date of January 26, 2026. This delivery order is issued without a set-aside designation and represents a child contract under one of Allergan's larger indefinite delivery vehicles—specifically the $13.5...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, for Natrelle Inspira SCF 695CC breast implants. The delivery order, which is classified as a child contract, is scheduled for completion by January 13, 2026, and was awarded without any set-aside designation. This award falls under Allergan's larger Indefinite Delivery/Indefinite Quantity (IDV) vehicle—specifically the $13.5...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,300 delivery order on December 19, 2025, for Natrelle Inspira SCF 450CC breast implants. This fixed-price contract with economic price adjustment serves the Medical Supply Chain division of the Defense Logistics Agency and will be completed by December 23, 2025. The contract carries no set-aside designation, reflecting Allergan's established status as a sole-source provider of specialized breast implant devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814 fixed-price delivery order with economic price adjustment on January 20, 2026, for Natrelle Inspira SCX 525CC breast implants. The contract, which is a child order under a larger Indefinite Delivery/Indefinite Quantity vehicle, is scheduled for completion by January 22, 2026, and will be performed at Allergan's facility in Irvine, California. This delivery order was issued without a set-aside designation, reflecting...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on January 22, 2026, for Natrelle Inspira SSM 520cc breast implants. The contract, which carries an ultimate completion date of January 26, 2026, represents a child order issued against one of Allergan's larger Indefinite Delivery Vehicle contracts established with DLA Troop Support Medical. This award was made without a set-aside...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $2,400 for Natrelle Inspira SSLP 320cc breast implants by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment will be performed at the company's facility in Irvine, California, with an ultimate completion date of February 6, 2026. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,607.00 fixed-price delivery order on February 3, 2026, for Natrelle Inspira SCF 605CC breast implants to be delivered by February 5, 2026. This contract is issued under Allergan's existing Indefinite Delivery/Indefinite Quantity (IDV) vehicle with the Defense Logistics Agency Troop Support Medical, a $13.5 million contract established on December 8, 2022, that covers Natrelle breast implants and related surgical devices. The work...